Cynthia Tracy Recognized for Work to Update Atrial Fibrillation Guidelines for the ACC and AHA

Dr. Cynthia Tracy posing for a portrait

Cynthia Tracy, M.D., director of electrophysiology, associate director of cardiology, and professor of medicine at the George Washington University School of Medicine and Health Sciences, was recently recognized by the American College of Cardiology (ACC) and the American Heart Association (AHA) for her contribution to the 2014 Guideline for the Management of Patients with Atrial Fibrillation.

The ACC/AHA clinical practice guidelines serve to provide evidence-based guidance to physicians and other health care providers practicing cardiovascular medicine. Moreover, these guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.

Tracy was chosen for this initiative to provide her expertise and leadership at a national level. Her service to the cardiology community at large, as well as exceptional academic citizenship was recognized as highly valued by the ACC and AHA. These guidelines will have important benefits to cardiovascular health care professionals and patients.

The updated guidelines have been jointly published in the Journal of the American College of Cardiology and Circulation.

Latest News

Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…